Uridine and its nucleotides: biological actions, therapeutic potentials

被引:175
作者
Connolly, GP
Duley, JA
机构
[1] Guys Hosp, Dept Chem Pathol, Purine Neurosci Lab, London SE1 9RT, England
[2] Guys Hosp, Guys & St Thomas NHS Trust, Purine Res Lab, London SE1 9RT, England
关键词
D O I
10.1016/S0165-6147(99)01298-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many disorders of pyrimidine metabolism and those that involve an alteration in uridine metabolism have neurological and systemic effects, which provide insights into the biological activity of uridine and its analogues. Studies of the metabolism and actions of pyrimidines have uncovered a wealth of information on how these endogenous metabolites modulate cell physiology. In this article, the roles for the pyrimidine nucleoside uridine and its nucleotide derivatives in the regulation of a number of biological systems are examined and benefits of further studies are outlined. An understanding of how uridine and its nucleotides modulate such vastly complicated biological systems should ultimately lead to the development of new ways for modulating human physiology in both normal and diseased states. Likely targets for therapy include the respiratory, circulatory, reproductive, and nervous systems, and the treatment of cancer and HIV infection.
引用
收藏
页码:218 / 225
页数:10
相关论文
共 65 条
  • [1] EFFECTS OF CHRONIC TREATMENT WITH URIDINE ON STRIATAL DOPAMINE RELEASE AND DOPAMINE RELATED BEHAVIORS IN THE ABSENCE OR THE PRESENCE OF CHRONIC TREATMENT WITH HALOPERIDOL
    AGNATI, LF
    FUXE, K
    RUGGERI, M
    PICH, EM
    BENFENATI, F
    VOLTERRA, V
    UNGERSTEDT, U
    ZINI, I
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1989, 15 (01) : 107 - 113
  • [2] INTRAVENOUS URIDINE TREATMENT ANTAGONIZES HYPOGLYCEMIA-INDUCED REDUCTION IN BRAIN SOMATOSTATIN-LIKE IMMUNOREACTIVITY
    AGNATI, LF
    FUXE, K
    ENEROTH, P
    ZINI, I
    HARFSTRAND, A
    GRIMALDI, R
    ZOLI, M
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1986, 126 (04): : 525 - 531
  • [3] Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides
    Anderson, CM
    Parkinson, FE
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (10) : 387 - 392
  • [4] Nucleotide receptors in the nervous system - An abundant component using diverse transduction mechanisms
    Barnard, EA
    Simon, J
    Webb, TE
    [J]. MOLECULAR NEUROBIOLOGY, 1997, 15 (02) : 103 - 129
  • [5] BECROFT DMO, 1969, PEDIAT PHARM THER, V75, P885
  • [6] CEREBRAL ENDOGENOUS SUBSTRATE UTILIZATION DURING THE RECOVERY PERIOD AFTER PROFOUND HYPOGLYCEMIA
    BENZI, G
    VILLA, RF
    DOSSENA, M
    VERCESI, L
    GORINI, A
    PASTORIS, O
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1984, 11 (04) : 437 - 450
  • [7] Berman P, 1984, Adv Exp Med Biol, V165 Pt A, P367
  • [8] Bernardini R, 1983, Acta Eur Fertil, V14, P341
  • [9] UTP-TRIGGERED AND ATP-TRIGGERED TRANSMITTER RELEASE FROM RAT SYMPATHETIC NEURONS VIA SEPARATE RECEPTORS
    BOEHM, S
    HUCK, S
    ILLES, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) : 2341 - 2343
  • [10] Bonavita V, 1975, Acta Neurol (Napoli), V30, P30